Document Library

IDTitleContentImageDateCategoriesLink
11690October 2024NEL Prescribing and Medicines Newsletter – GP Practices – Oct 24 – FINAL2024/10/30
8458CNBA guidance flow chart TH primary careCNBA guidance flow chart TH primary care2024/04/22
82832024/04/02
8025CEW Referral FormUpdated CEW_Referral_Form_Reviewed_oct20222024/03/18
7462Real nappies 2024Real nappies 20242024/02/27
7456_KBT ELWA Regional Reusable Nappy Scheme2024/02/27
7276INEL-Ophtalmology-SPoAINEL-Ophtalmology-SPoA-Feb-20232024/02/08
7093UKHSA London Region Notification of Infectious Disease FormUKHSA London Region Notification of Infectious Disease Form Aug 20232024/01/26
7091UKHSA London Region Health Protection Team Contact DetailsUKHSA London Region Health Protection Team Contact Details Aug 23 GPs2024/01/26
7056Pan London Guide for Professionals Involved in Unexpected Deaths in the CommunityPan London Guide to Death in Community Response V1.02024/01/26
7057Gall-bladder-polyps (1)Gall-bladder-polyps (1)2024/01/26
7050Minimum Retest IntervalsMinimum Retest Intervals for Ferritin B12 and Folate – Read-Only2024/01/26
7038Blood glucose test strips guideline (NEL) V2_12.2023Blood glucose test strips guideline (NEL) V2_12.20232024/01/26
7034MSQG Medicines Safety Newsletter January 2024MSQG Medicines Safety Newsletter January 2024 FINAL2024/01/26
7031NHS App For Repeat Prescriptions Toolkit_ Increasing Uptake of the App_26_01_2024NHS App For Repeat Prescriptions Toolkit_ Increasing Uptake of the App_26_01_20242024/01/26
7027NHS App For Repeat Prescriptions Toolkit_ Promoting the app to Patients26_01_2024NHS App For Repeat Prescriptions Toolkit_ Promoting the app to Patients26_01_20242024/01/26
7023NHS App For Repeat Prescriptions Toolkit_ Tracking NHS App Data26_01_2024NHS App For Repeat Prescriptions Toolkit_ Tracking NHS App Data26_01_20242024/01/26
6916AFS policy 2024AFS policy January 20242024/01/22
6467Community Pharmacy Prescribing Medicines Newsletter December 2023NEL PM NL Community Pharmacy December 23 Final (1)2024/01/08
6459NEL Rheumatoid Arthritis PathwayRheumatoid arthritis HCD pathway (NEL) V2_12.20232024/01/08
6452Calcium and vitamin D (colecalciferol) preparations for adults at risk of osteoporosis guidance (NEL)Calcium and vitamin D (colecalciferol) preparations for adults at risk of osteoporosis guidance (NEL)_12.20232024/01/08
6448Shared care REFUSAL letter – primary care to specialist draft (NEL)Shared care REFUSAL letter – primary care to specialist (NEL)_12.20232024/01/08
6444Shared care ACCEPTANCE letter – primary care to specialist (NEL)Shared care ACCEPTANCE letter – primary care to specialist (NEL)_12.20232024/01/08
6441Shared care REQUEST letter – specialist to primary care (NEL)Shared care REQUEST letter – specialist to primary care (NEL)_12.20232024/01/08
6437Shared Care Guideline for Refractory Secondary Hyperparathyroidism (SHPT) in adult patients with End Stage Renal Disease (ESRD)Cinacalcet SCG2024/01/08
6433Guideline for management of type 2 diabetes (NEL) V2Type 2 diabetes management guideline (NEL) V2_12.20232024/01/08
6429Virtual Treatment Pathways for Simple FracturesGP communications – VTP2024/01/08
5950Unlicensed specials prescribing resources  C&H (requires review)Unlicensed specials prescribing resources 06.20182023/12/17
5946Repeat prescriptions ordering guidance C&H (requires review)Repeat prescriptions ordering guidance 01.20162023/12/17
5944Prescribing checklist for primary care prescribers C&H (requires review)Prescribing cheklist for primary care prescribers 04.20192023/12/17
5942Non-medical prescribing policy for use in General Practice C&H (requires review)Non-medical Prescribing Policy for use in General Practice_08.20172023/12/17
5937Vitamin D deficiency pathway (children) C&H Vitamin D deficiency in primary care – Children pathway_12.20212023/12/17
5935Vitamin D deficiency pathway (adults) C&H Vitamin D deficiency in primary care – Adult pathway_12.20212023/12/17
5932Guidance for the prescribing of gluten free foods on NHS prescriptions C&H (requires review)Guidance for the prescribing of gluten free foods on NHS prescriptions_12.20192023/12/17
5930Prescribing of specialist infant formulae C&H (requires review)Food and nutrition guidelines – The prescribing of specialist infant formulae_03.20132023/12/17
5928Prescribing of oral nutritional supplements (adults) C&H Prescribing of oral nutritional supplements_03.20222023/12/17
5924Overactive bladder syndrome management with antimuscarinic drugs C&H (requires review)Overactive bladder syndrome management with antimuscarinic drugs2023/12/17
5921Menopause management guideline C&H (requires review)Menopause management guideline_12.20182023/12/17
5919Erectile dysfunction management C&H (requires review)Erectile dysfunction management_03.20132023/12/17
5915Prescribing guideline for dry eye syndrome C&H (requires review)Dry_eyes_syndrome_guidelines_06.20162023/12/17
5911Dressings formulary (City & Hackney)Dressings formulary_12.20162023/12/17
5909Continence formulary (City & Hackney)Continence formulary2023/12/17
5905Bisphosphonate drug holidays guidance C&HGuidance for bisphosphonate drug holidays_05.2022 corrected algorithm2023/12/17
5901Asthma and COPD inhaler technique information flashcards C&H (requires review)Inhaler flashcards 02.20182023/12/17
5831Anticoagulation – DOAC initiation guideCH GPC DOAC initiation_08.20222023/12/11
5826Anal fissure management guidance in adultsAnal fissure management – Adults2023/12/11
5815NEL Atopic Dermatitis pathwayAtopic dermatitis HCD pathway (NEL) V1_11.2023 (1)2023/12/11
5744Tower Hamlets – Treatment Pathway for Urinary Incontinence in Adults (Primary Care)Treatment Pathway for Urinary Incontinence in Adults (Primary Care)2023/12/04
5741Tower Hamlets – Stoma Prescribing Guidelines FINAL TH versionStoma Prescribing Guidelines FINAL TH version2023/12/04
5736Tower Hamlets – Special Products Alternative RecommendationSpecial Products Recommended Alternatives 20192023/12/04
5731Tower Hamlets – Sodium Valporate Risk Acknowledgement FormSodium Valproate- completion of RA forms2023/12/04
5726Tower Hamlets – Risperidone Consta Information SheetRisperidone Consta Information Sheet2023/12/04
5721Tower Hamlets -Recommendations for Oral supplement for advanced CKD patientsRequesting supplements for Tower Hamlets – BARTS DIETITIAN INFO (1)2023/12/04
5714Tower Hamlets – Recommendations for Gluten Free PrescribingRecommendations for Oral supplement for advanced CKD patients2023/12/04
5710Policy use of a Pan-London Symptom Control MAAR Chart for subcutaneous and intramuscular medsPolicy use of a Pan-London Symptom Control MAAR Chart for subcutaneous and intramuscular meds (2)2023/12/04
5706Tower Hamlets – Paediatric Vitamin D GuidelinesPaediatric Vitamin D Guidelines – 20172023/12/04
5702Naloxone Prenoxad Guidance FinalNaloxone Prenoxad Guidance Final2023/12/04
5695Psoriasis HCD pathway (NEL) V1.3_11.2023Psoriasis HCD pathway (NEL) V1.3_11.20232023/12/04
5617NHS App digital prescriptions web banner 400×4002023/11/30
5608NHS App digital prescriptions leaflet – final versionNHS App digital prescriptions leaflet – final version2023/11/30
5606NHS App Digital Prescriptions A4 poster- final versionNHS App Digital Prescriptions A4 poster- final version2023/11/30
5586NHS App digital prescriptions Facebook image 1200×6302023/11/30
5583Social Media ContentSocial Media Content2023/11/30
5581Sample newsletter contentSample newsletter content2023/11/30
5579Sample letter to pharmaciesSample letter to pharmacies2023/11/30
5577Sample letter for surgeriesSample letter for surgeries2023/11/30
5575Additional InformationAdditional Information Attachment2023/11/30
5483Melatonin Guideline FinalMelatonin Guideline Final2023/11/28
5478Management of patients on Insulin TherapyManagement of patients on Insulin Therapy2023/11/28
5474Local implementation of the NHS Discharge Medicines ServiceLocal implementation of the NHS Discharge Medicines Service2023/11/28
5470HYDROXYCARBAMIDE (HYDROXYUREA) For the Management of Sickle Cell Disease in Adults and ChildrenTower Hamlets – Nutrition & Blood – HYDROXYCARBAMIDE (HYDROXYUREA) For the Management of Sickle Cell …2023/11/28
5466How to apply for a prescribing code for NMPs – Guide for Practice ManagerHow to apply for NMP Prescribing Code. Summary of process2023/11/28
5461Glycopyrronium Bromide (Sialanar®) Prescribing InformationGlycopyrronium Bromide (Sialanar) Prescribing Information2023/11/28
5456NEL Safe Fasting During Ramadan Guidance v1_03.2023NEL Safe Fasting During Ramadan Guidance v1_03.20232023/11/28
5452Emollient Formulary and Guidance – 2019 UpdateEmollient Formulary and Guidance – 2019 Update2023/11/28
5450Bath and Shower Preparations Position StatementBath and Shower Preparations Position Statement2023/11/28
5420Medicines Optimisation CQC requirementsCQC _Medicines optimisation_requirements- Place PLT_slides 20232023/11/22
5378Emollient prescribing guidelines for primary care (NEL) v1.0_10.2023Emollient prescribing guidelines for primary care (NEL) v1.0_10.20232023/11/22
5239Melatonin formulary choices summary_10.2023Melatonin formulary choices summary_10.20232023/11/21
5237Melatonin QIPP implementation protocol_10.2023Melatonin QIPP implementation protocol_10.20232023/11/21
5228Children’s Atopic Eczema Primary Care Clinical PathwayTower Hamlets Eczema Pathway v9, 17.11.232023/11/21
5197Emergency kit finalEmergency kit final2023/11/08
5191Step by Step Guide for Recording Awarness sessionsStep by Step Guide for Recording Awarness sessions2023/11/08
5138NEL Medicines Prescribing Newsletter September 2023_NEL Medicines Prescribing Newsletter September 2023_2023/11/07
5133MSQG-Medicines-Safety-Newsletter-Issue-2-August-2023-FINALMSQG-Medicines-Safety-Newsletter-Issue-2-August-2023-FINAL2023/11/07
5072Nel P&M Newsletter Nov 23 amendedNel P&M Newsletter Nov 23 amended2023/11/07
5051Inflammatory bowel disease pathway (NEL) V1.2_10.2023Inflammatory bowel disease pathway (NEL) V1.2_10.20232023/11/06
5040CKD in primary care – Early identification and optimisation pathway (London Kidney Network)_09.2022CKD in primary care – Early identification and optimisation pathway (London Kidney Network)_09.20222023/11/03
5032Primary care guidance for prescribing and supplying inclisiran (NEL)_09.2023Primary care guidance for prescribing and supplying inclisiran (NEL)_09.20232023/11/03
5018Rivaroxaban VTE – TOC BHRivaroxaban VTE – TOC BH2023/10/31
5015Rivaroxaban in Paediatrics – TOC BHRivaroxaban in Paediatrics – TOC BH2023/10/31
5012Rivaroxaban counselling checklistRivaroxaban counselling checklist2023/10/31
5010Rivaroxaban AF – TOC BHRivaroxaban AF – TOC BH2023/10/31
5007Edoxaban VTE – TOC BHEdoxaban VTE – TOC BH2023/10/31
5005Edoxaban counselling checklistEdoxaban counselling checklist2023/10/31
5001Edoxaban AF – TOC BHEdoxaban AF – TOC BH2023/10/31
4998Dabigatran VTE – TOC BHDabigatran VTE – TOC BH2023/10/31
4995Dabigatran counselling checklistDabigatran counselling checklist2023/10/31
4992Dabigatran AF – TOC BHDabigatran AF – TOC BH2023/10/31
4989Apixaban VTE – TOC BHApixaban VTE – TOC BH2023/10/31
4986Apixaban counselling checklistApixaban counselling checklist2023/10/31
4983Apixaban AF – TOC BHApixaban AF – TOC BH2023/10/31
4976Shared Care Guideline SMI_02.2018Shared Care Guideline SMI_02.20182023/10/26
4973Prescribing Pathway – Use of Donepezil Galantamine Rivastigmine and Memantine in Dementia 03.2021Prescribing Pathway – Use of Donepezil Galantamine Rivastigmine and Memantine in Dementia 03.20212023/10/26
4970Melatonin paed SCG_09.2021Melatonin paed SCG_09.20212023/10/26
4968ELFT – protocol for safe use of lithium v4 11.2020ELFT – protocol for safe use of lithium v4 11.20202023/10/26
4965ADHD Children V9 ELFT_11.2021ADHD Children V9 ELFT_11.20212023/10/26
4956Denosumab SCG (2021 Update)Denosumab SCG (2021 Update)2023/10/26
4953Degarelix Shared Care GuidelineDegarelix Shared Care Guideline2023/10/26
4941Patient Access to Online Records – September 2023Patient Access to Online Records – September 20232023/10/26
4928BHR Click supporting information letterBHR Click supporting information letter2023/10/26
4926BHR wound care formularyBHR wound care formulary2023/10/26
4887Using the NHS App Guidance for GP Practices v1.0.23oct2024Using the NHS App Guidance for GP Practices v1.0.23oct20242023/10/24
4884NHS App For Repeat Prescriptions Toolkit_ Promoting the app to Patients (1)24oct2023NHS App For Repeat Prescriptions Toolkit_ Promoting the app to Patients (1)24oct20232023/10/24
4881NHS App For Repeat Prescriptions Toolkit_ Increasing Uptake of the App (1)24oct2023NHS App For Repeat Prescriptions Toolkit_ Increasing Uptake of the App (1)24oct20232023/10/24
4852Asthma RegistryCopy of AFS Excel list2023/10/20
4849AFS policyAFS policy (7)(2)2023/10/20
4846AFS self certifcation form 2023AFS self certifcation form 20232023/10/20
4844relaunch letterrelaunch letter2023/10/20
4765Azathioprine, mercaptopurine, oral methotrexate (inflammatory bowel disease) SCG_04.2021Azathioprine, mercaptopurine, oral methotrexate (inflammatory bowel disease) SCG_04.20212023/10/18
4742UKHSA London Region Health Protection Team Contact DetailsUKHSA London Region Health Protection Team Contact Details Aug 23 GPs2023/10/18
4735Birth reflections Referral Form 2023Birth reflections Referral Form 20232023/10/18
4732Birth Options Referral Form new version May 2023 by P.DikeBirth Options Referral Form new version May 2023 by P.Dike2023/10/18
4728Information about different services – cleanInformation about different services – clean2023/10/18
4726Edenbridge Apex “How to Guide”Edenbridge Apex – How to Guide2023/10/18
4714fluoxetinefluoxetine2023/10/18
4711EscitalopramEscitalopram2023/10/18
4708(NH & WF) Prescribing of coagulometers(NH & WF) Prescribing of coagulometers2023/10/18
4703(NEL) Hospital only list(NEL) Hospital only list2023/10/18
4700(BHR) Hospital only list(BHR) Hospital only list2023/10/18
4684ADHD PILADHD PIL2023/10/17
4682ADHD medication shortage memo V1.0ADHD medication shortage memo V1.02023/10/17
4680ADHD medication shortage easy-read patient information leaflet V1.0ADHD medication shortage easy-read patient information leaflet V1.02023/10/17
4678ADHD information schoolsADHD information schools2023/10/17
4662NEL Position statement semaglutide and liraglutide for obesity_06.2023NEL Position statement semaglutide and liraglutide for obesity_06.20232023/10/17
4657LPP and London Diabetes Network joint statement: Access to continuous glucose monitors for adults living with type 2 diabetes in London LPP and London Diabetes Network joint statement: Access to continuous glucose monitors for adults living …2023/10/17
4654Interim positional statement for the use of Dexcom ONE real time continuous glucose monitor (NEL)Interim positional statement for the use of Dexcom ONE real time continuous glucose monitor (NEL)2023/10/17
4652Position statement on generic and brand prescribing (NEL)Position statement on generic and brand prescribing (NEL)2023/10/17
4648Practice Dashboard -30.09.2023Practice Dashboard -30.09.20232023/10/17
4644CPCS DATA – 30.9.2023CPCS DATA – 30.9.20232023/10/17
4576Community Children Asthma – SpacersSpacers for intranet Final2023/10/12,
4571Interpretation tool for Observed Peak FlowInterpretation tool for observed peak flow2023/10/12
4568Word version – Asthma patient questionnaire (icebreaker)Word version – Asthma patient questionnaire (icebreaker)2023/10/12
4566Word version – Asthma Control TestWord version – Asthma Control Test2023/10/12
4564PDF version – Asthma Control TestPDF version – Asthma Control Test2023/10/12
4562Inhaler technique assessment – Checklist for healthcare professionalsInhaler technique assessment – Checklist for healthcare professionals2023/10/12
4558Enhanced asthma reviews – Checklist for healthcare professionalsEnhanced asthma reviews – Checklist for healthcare professionals2023/10/12
4556Childhood asthma control testChildhood asthma control test2023/10/12
4553Wheeze planmonkey plan primary care version2023/10/12
4551Symbicort Action PlanSymbicort Action Plan2023/10/12
4548Asthma/wheeze information leaflet and weaning planAsthma and Wheeze how to keep(1)2023/10/12
4526Cervical Screening Management Systemcervical screening management system user guide2023/10/05
4518Policy use of a Pan-London Symptom Control MAAR Chart for subcutaneous and intramuscular meds (1)Policy use of a Pan-London Symptom Control MAAR Chart for subcutaneous and intramuscular meds (1)2023/10/05
4456TH Psychology DirectoryCopy of TH Psychology Directory Jan 20222023/10/03
4452CNBA guidance flow chart TH primary care (3)2023/10/03
4446Practice Dashboard -31.8.2023Practice Dashboard -31.8.20232023/10/03
4443CPCS DATA – 31.8.2023CPCS DATA – 31.8.20232023/10/03,
4423MSQG Medicines Safety Newsletter Issue 2MSQG Medicines Safety Newsletter Issue 22023/10/03
4417Methylphenidate, lisdexamfetamine, dexamfetamine and atomoxetine (under 18 years ADHD) SCG_11.2018Methylphenidate, lisdexamfetamine, dexamfetamine and atomoxetine (under 18 years ADHD) SCG_11.20182023/10/02
4414Melatonin (sleep disorders and difficulties in under 18 years) SCG_07.2018Melatonin (sleep disorders and difficulties in under 18 years) SCG_07.20182023/10/02
4411Lithium (mental health) treatment protocol_05.2016Lithium (mental health) treatment protocol_05.20162023/10/02
4408Donepezil, galantamine, rivastigmine, memantine (Alzheimer’s disease) SCG_06.2023 Donepezil, galantamine, rivastigmine, memantine (Alzheimer’s disease) SCG_06.2023 2023/10/02
4404Apomorphine (Parkinson’s disease) SCG_06.2018 Apomorphine (Parkinson’s disease) SCG_06.2018 2023/10/02
4399Adult Asthma PlanAsthma Plan 12+2023/10/02
4372Mild to moderateAMP mild to moderate v92023/10/02
4370Jext with asthmaAMP Jext with asthma v92023/10/02
4368AMP Jext no asthma v9AMP Jext no asthma v92023/10/02
4365Epipen with asthmaAMP Epipen with asthma v9AMP Epipen with asthma v92023/10/02
4363Epipen no asthmaAMP Epipen no asthma v92023/10/02
4361AMP Emerade with asthma v9AMP Emerade with asthma v9 spoiled2023/10/02
4358AMP Emerade no asthma v9AMP Emerade no asthma v92023/10/02
4351Tower Hamlets Asthma and Wheeze PathwayTower Hamlets Asthma and Wheeze Pathway2023/10/02
4349Paeds atopic eczema treatmentPaeds atopic eczema treatment 2020 (1) (1)2023/10/02
4346No More Weaning Plan for children with wheeze/asthmaPaeds atopic eczema treatment 2020Salbutamol usage pathway Sept 2022 – RLH version (1) (1)2023/10/02
4344Guide to children inhalers and placebosGuide to children inhalers and placebos (1)2023/10/02
4342Children’s Acute Asthma Exacerbation PathwayAcute Asthma Exacerbation Pathway(2) (1)2023/10/02
4340BHTHT Paediatric Asthma GuidelinesBHTHT Paediatric Asthma Guidelines Jan 2020 (1)2023/10/02
4338Algorithm – Rhinitis PCGLAlgorithm-RhinitisPCGL(1)(1)2023/10/02
4329Advice and support for parents who smokeStop Smoking Letter FINAL VERSION UNEDITABLE2023/10/02
4327Anaphylaxis Campaign Childrens PosterAnaphylaxis Campaign Kids Poster DIGITAL2023/10/02
4325Anaphylaxis Campaign Adult PosterAnaphylaxis Campaign Adult Poster DIGITAL2023/10/02
4323NUT Free school posterNUT Free school poster(4) (003)2023/10/02
4316ELFT PTS low cost therapy optionsELFT PTS low cost therapy options2023/10/02
4310Referral criteria for Diabetes Specialist Dietetic service 2023Referral criteria for Diabetes Specialist Dietetic service 20232023/10/02
4307NEL – Discharge Medicines Service PresentationNEL – Discharge Medicines Service Presentation2023/10/01
4303NEL Discharge Medicines Service PathwayNEL Discharge Medicines Service Pathway2023/10/01
4301NEL – Discharge Medicines Service Referral FormNEL – Discharge Medicines Service Referral Form2023/10/01
4296Waltham Forest End of Life Care Stock ListWaltham Forest End of Life Care Stock List2023/10/01
4293Waltham Forest End of Life Care Service SpecificationWaltham Forest End of Life Care Service Specification2023/10/01
4290Waltham Forest End of Life CareWaltham Forest End of Life Care2023/10/01
4280Newham End of Life Care Stock ListNewham End of Life Care Stock List2023/10/01
4277Newham End of Life Care Service SpecificationNewham End of Life Care Service Specification2023/10/01
4273Newham – End of Life Community Pharmacy Newham – End of Life Community Pharmacy 2023/10/01
4263Newham Latent TB Service – Participating PharmaciesNewhaNewham Latent TB Service – Participating Pharmaciesm Latent TB Service Pharmacies2023/10/01
4231WEL Pain Guidelines V2 TH VERSIONWEL Pain Guidelines V2 TH VERSION2023/09/28
4229Anti-Epileptic Drug Interface DocumentAnti Epileptic Drug Interface Document Final(1)2023/09/28
4191PHE guidance on use of antiviral agents for the treatment and prophylaxis of seasonal influenzaPHE_guidance_antivirals_influenza_2019202023/09/28
4187Pneumonia (community-acquired): antimicrobial prescribingCommunity Acquired Pneumonia NICE Visual Summary Sept 20192023/09/28
4180NEL Antimicrobial Prescribing Guidance V1.6 Mar 23NEL Antimicrobial Prescribing Guidance V1.6 Mar 232023/09/28
4176Reframing Resistance: The Framing ToolkitReframing Resistance Toolkit Wellcome Trust (1)2023/09/28
4173Key AMR ResourcesKey AMR Resources 20192023/09/28
4169UTI Assessment Tool for Care Home StaffUTI Assessment Tool for Care Home Staff V52023/09/28
4165Hydration Guidance for Care HomesHydration Guidance for Care Homes V32023/09/28
4121EH_OneMinuteGuideEH_OneMinuteGuide2023/09/28
4118A Guide to the Early Help OfferEarlyHelp Offer2023/09/28
4072DMC Dermatology Formulary 2021DMC Dermatology Formulary 20212023/09/26
4053How to Refer to Children’s Social Care for a Statutory AssessmentGuide on how to refer interagency20162023/09/25
4043Bruising or suspected non accidental in childrenBruising or suspected non accidental in children V52023/09/25
3951Tower Hamlets – Nutrition & Blood – Requesting supplements for Tower Hamlets patients in the community: Guidance (Requires review)Tower Hamlets – Nutrition & Blood – Requesting supplements for Tower Hamlets patients in the …2023/09/22
3947Tower Hamlets – Nutrition & Blood – Vitamin D guidelines Adults (Requires review)Tower Hamlets – Nutrition & Blood – Vitamin D guidelines Adults (Requires review)2023/09/22
3941Tower Hamlets – Weight Management – GLP-1 Analogue Position Statement for Weight Management (Requires review)Tower Hamlets – Weight Management – GLP-1 Analogue Position Statement for Weight Management (Requires review)2023/09/22
3937Tower Hamlets – Nutrition & Blood – First Line Nutrition Support Products and Specialist Infant Formula (Requires review)Tower Hamlets – Nutrition & Blood – First Line Nutrition Support Products and Specialist Infant …2023/09/22
3932Tower Hamlets – Community Pharmacy – DMS Referral form – v1 (Requires review)Tower Hamlets – Community Pharmacy – DMS Referral form – v1 (Requires review)2023/09/21
3923Tower Hamlets – Infection – UTI Assessment Tool for Care Home Staff V 5 (Requires review)Tower Hamlets – Infection – UTI Assessment Tool for Care Home Staff V 5 (Requires …2023/09/21
3919Tower Hamlets – Infection – Hydration Poster Professional 1-8 ELHCP (Requires review)Tower Hamlets – Infection – Hydration Poster Professional 1-8 ELHCP (Requires review)2023/09/21
3917Tower Hamlets – Infection – Hydration Guidance for Care Homes V 3 (Requires review)Tower Hamlets – Infection – Hydration Guidance for Care Homes V 3 (Requires review)2023/09/21
3908Tower Hamlets – Diabetes – WEL CCGs Position Statement for the Prescribing of FreeStyle Libre (V2.1) (Requires review)WEL CCGs Position Statement for Flash Glucose Monitoring2023/09/21
3906Tower Hamlets – Diabetes – WEL CCGs FreeStyle Libre Transfer of Prescribing form (Requires review)Tower Hamlets – Diabetes – WEL CCGs FreeStyle Libre Transfer of Prescribing form (Requires review)2023/09/21
3904Tower Hamlets – Diabetes – WEL CCGs FreeStyle Libre 6-9 month review form (Requires review)Tower Hamlets – Diabetes – WEL CCGs FreeStyle Libre 6-9 month review form (Requires review)2023/09/21
3900Tower Hamlets – Diabetes – Update on Free Style Libre clinical waste disposal (Requires review)Tower Hamlets – Diabetes – Update on Free Style Libre clinical waste disposal (Requires review)2023/09/21
3898Tower Hamlets – Diabetes – Transfer of Care Doc – Dapagliflozin with insulin for treating type 1 diabetes (Requires review)Tower Hamlets – Diabetes – Transfer of Care Doc – Dapagliflozin with insulin for treating …2023/09/21
3895Tower Hamlets – Diabetes – TNW Position Statement for CGM (Requires review)Tower Hamlets – Diabetes – TNW Position Statement for CGM (Requires review)2023/09/21
3892Tower Hamlets – Diabetes – North East London Blood Test Strips Guideline (Requires review)Tower Hamlets – Diabetes – North East London Blood Test Strips Guideline (Requires review)2023/09/21
3890Tower Hamlets – Diabetes – Needles for Pre-filled and Reusable Insulin Pens Position Statement (Requires review)Tower Hamlets – Diabetes – Needles for Pre-filled and Reusable Insulin Pens Position Statement (Requires …2023/09/21
3888Tower Hamlets – Diabetes – Free Style Libre Primary Care Information Sheet (Requires review)Tower Hamlets – Diabetes – Free Style Libre Primary Care Information Sheet (Requires review)2023/09/21
3885Tower Hamlets – Diabetes – Appendix 2 – When to Check Ketones (Dapagliflozin in Type 1 DM Resources) (Requires review)Tower Hamlets – Diabetes – Appendix 2 – When to Check Ketones (Dapagliflozin in Type …2023/09/21
3881Tower Hamlets – Respiratory – Home Oxygen Service in WEL CCGs Final (Requires review)Tower Hamlets – Respiratory – Home Oxygen Service in WEL CCGs Final (Requires review)2023/09/21
3879Tower Hamlets – Respiratory – Home Oxygen Risk Mitigation Form (IHORM) Support Notes (Requires review)Tower Hamlets – Respiratory – Home Oxygen Risk Mitigation Form (IHORM) Support Notes (Requires review)2023/09/21
3877Tower Hamlets – Respiratory – Home Oxygen Risk Mitigation Form (IHORM) and Home Oxygen Consent Form (HOCF) (Requires review)Tower Hamlets – Respiratory – Home Oxygen Risk Mitigation Form (IHORM) and Home Oxygen Consent …2023/09/21
3875Tower Hamlets – Respiratory – Home Oxygen Documentation Brief (Requires review)Tower Hamlets – Respiratory – Home Oxygen Documentation Brief (Requires review)2023/09/21
3873Tower Hamlets – Respiratory – FAQ IHORM and Consent form March 17 (Requires review)Tower Hamlets – Respiratory – FAQ IHORM and Consent form March 17 (Requires review)2023/09/21
3871Tower Hamlets – Respiratory – BHTHT Paediatric Asthma Guidelines Jan 2020 pdf (Requires review)Tower Hamlets – Respiratory – BHTHT Paediatric Asthma Guidelines Jan 2020 pdf (Requires review)2023/09/21
3851Mellow parentingINFO for parents leaflet toy house2023/09/21
3849Toy HouseToy House REFERRAL FORM11092015C2023/09/21
3844CEDS-CYPRef info 1_ Information for Referrers_08.07.16 (1)2023/09/21
3836Community Eating Disorder Service for Children and Young PeopleCEDS-CYP_Service_Leaflet 07.162023/09/21
3834Referral Pathway for Children and Young PeopleReferral Pathway for CYP suspected of ED in a Primary Care Setting_5.8.162023/09/21
3824ASD referral criteriaASD Community Paediatrics referral criteria (1)2023/09/21
3814Schools AllocationSchool Allocation List 7 Sept2023/09/21
3810Tower Hamlets – Mental Health – Deprescribing guidance from ELFT for Trimipramine (Requires review)Tower Hamlets – Mental Health – Deprescribing guidance from ELFT for Trimipramine (Requires review)2023/09/20
3808Tower Hamlets – Mental Health – Deprescribing guidance from ELFT for Doxepin (Requires review)Tower Hamlets – Mental Health – Deprescribing guidance from ELFT for Doxepin (Requires review)2023/09/20
3806Tower Hamlets – Mental Health – Deprescribing guidance from ELFT for Dosulepin (Requires review)Tower Hamlets – Mental Health – Deprescribing guidance from ELFT for Dosulepin (Requires review)2023/09/20
3801Tower Hamlets – Shared Care Guideline – Antiandrogens 02.2005 (Requires review)Tower Hamlets – Shared Care Guideline – Antiandrogens 02.2005 (Requires review)2023/09/20
3797Tower Hamlets – Shared Care Guideline – Triptorelin 07.2012 (Requires review)Tower Hamlets – Shared Care Guideline – Triptorelin 07.2012 (Requires review)2023/09/20
3795Tower Hamlets – Shared Care Guideline – Sulfasalazine 02.2005 (Requires review)Tower Hamlets – Shared Care Guideline – Sulfasalazine 02.2005 (Requires review)2023/09/20
3793Tower Hamlets – Shared Care Guideline – Shared Care Guideline for the management of Pseudomonas aeruginosa lung infection in Adult Non-Cystic Fibrosis Bronchiectasis (Requires review)Tower Hamlets – Shared Care Guideline – Shared Care Guideline for the management of Pseudomonas …2023/09/20
3791Tower Hamlets – Shared Care Guideline – Shared Care Guideline for Somatropin use as Replacement in Adults with Growth Hormone  Deficiency (Requires review)Tower Hamlets – Shared Care Guideline – Shared Care Guideline for Somatropin use as Replacement …2023/09/20
3788Tower Hamlets – Shared Care Guideline – Shared Care Guideline for Recombinant Growth Hormone in Children (Requires review)Tower Hamlets – Shared Care Guideline – Shared Care Guideline for Recombinant Growth Hormone in …2023/09/20
3784Tower Hamlets – Shared Care Guideline – Shared Care Guideline for Phosphate Binders in  Hyperphosphataemia in Adults Patients with Chronic Kidney Disease (CKD) (Requires review)Tower Hamlets – Shared Care Guideline – Shared Care Guideline for Phosphate Binders in  Hyperphosphataemia …2023/09/20
3782Tower Hamlets – Shared Care Guideline – Severe Adult Psoriasis, Atopic Dermatitis and Eczema Shared Care Guideline (Requires review)Tower Hamlets – Shared Care Guideline – Severe Adult Psoriasis, Atopic Dermatitis and Eczema Shared …2023/09/20
3779Tower Hamlets – Shared Care Guideline – Sativex Shared Care Guideline (Requires review)Tower Hamlets – Shared Care Guideline – Sativex Shared Care Guideline (Requires review)2023/09/20
3774Tower Hamlets – Shared Care Guideline – Riluzole in Motor Neurone Disease Shared Care Guideline (Requires review)Tower Hamlets – Shared Care Guideline – Riluzole in Motor Neurone Disease Shared Care Guideline …2023/09/20
3772Tower Hamlets – Shared Care Guideline – P-Reset Substance Misuse Shared Care Guidance (Requires review)Tower Hamlets – Shared Care Guideline – P-Reset Substance Misuse Shared Care Guidance (Requires review)2023/09/20
3770Tower Hamlets – Shared Care Guideline – Penicillamine 02.2005 (Requires review)Tower Hamlets – Shared Care Guideline – Penicillamine 02.2005 (Requires review)2023/09/20
3768Tower Hamlets – Shared Care Guideline – Mycophenolate mofetil 07.2010 (Requires review)Tower Hamlets – Shared Care Guideline – Mycophenolate mofetil 07.2010 (Requires review)2023/09/20
3766Tower Hamlets – Shared Care Guideline – Mercaptopurine 10.2010 (Requires review)Tower Hamlets – Shared Care Guideline – Mercaptopurine 10.2010 (Requires review)2023/09/20
3761Tower Hamlets – Shared Care Guideline – Low Molecular Weight Heparin (LMWH) for treatment of thromboembolic disease Shared Care Guideline (Requires review)Tower Hamlets – Shared Care Guideline – Low Molecular Weight Heparin (LMWH) for treatment of …2023/09/20
3758Tower Hamlets – Shared Care Guideline – Liraglutide 02.2011 (Requires review)Tower Hamlets – Shared Care Guideline – Liraglutide 02.2011 (Requires review)2023/09/20
3756Tower Hamlets – Shared Care Guideline – Leflunomide 01.2010 (Requires review)Tower Hamlets – Shared Care Guideline – Leflunomide 01.2010 (Requires review)2023/09/20
3754Tower Hamlets – Shared Care Guideline – IBD Shared Care Guideline (Requires review)Tower Hamlets – Shared Care Guideline – IBD Shared Care Guideline (Requires review)2023/09/20
3733Tower Hamlets – Shared Care Guideline – Gonadorelin analogues 02.2005 (Requires review)Tower Hamlets – Shared Care Guideline – Gonadorelin analogues 02.2005 (Requires review)2023/09/20
3731Tower Hamlets – Shared Care Guideline – Exenatide 05.2009 (Requires review)Tower Hamlets – Shared Care Guideline – Exenatide 05.2009 (Requires review)2023/09/20
3729Tower Hamlets – Shared Care Guideline – ELFT Shared Care Guideline for ADHD Children and Young People 6-18 years (Requires review)Tower Hamlets – Shared Care Guideline – ELFT Shared Care Guideline for ADHD Children and …2023/09/20
3727Tower Hamlets – Shared Care Guideline – ELFT Lithium Protocol (Requires review)Tower Hamlets – Shared Care Guideline – ELFT Lithium Protocol (Requires review)2023/09/20
3725Tower Hamlets – Shared Care Guideline – Desmopressin intranasal 12.2013 (Requires review)Tower Hamlets – Shared Care Guideline – Desmopressin intranasal 12.2013 (Requires review)2023/09/20
3720Tower Hamlets – Shared Care Guideline – Denosumab (Prolia®) Shared Care Guideline – Treatment of osteoporosis in post-menopausal women (Requires review)Tower Hamlets – Shared Care Guideline – Denosumab (Prolia®) Shared Care Guideline – Treatment of …2023/09/20
3716Tower Hamlets – Shared Care Guideline – Degarelix Shared Care Guideline (Requires review)Tower Hamlets – Shared Care Guideline – Degarelix Shared Care Guideline (Requires review)2023/09/20
3710Tower Hamlets – Shared Care Guideline – Cinacalcet – Shared Care Guideline for Refractory Secondary Hyperparathyroidism (SHPT) in adult  patients with End Stage Renal Disease (ESRD) (Requires review)Tower Hamlets – Shared Care Guideline – Cinacalcet – Shared Care Guideline for Refractory Secondary …2023/09/20
3708Tower Hamlets – Shared Care Guideline – Azathioprine 01.2010 (Requires review)Tower Hamlets – Shared Care Guideline – Azathioprine 01.2010 (Requires review)2023/09/20
3702Tower Hamlets – CVD – Transfer of Care Guideline for Rivaroxaban in Paediatrics (Requires review)Tower Hamlets – CVD – Transfer of Care Guideline for Rivaroxaban in Paediatrics (Requires review)2023/09/20
3691Crisis PathwayCrisis Pathway Memo GPs 21 07 2020 final(1)2023/09/20
3689Crisis line and Cafe flyerCrisis line and Cafe flyer2023/09/20
3668Recharge postersRecharge posters (A4)(1)2023/09/20
3666Recharge partner communication toolkitRecharge partner communication toolkit2023/09/20
3631Tower Hamlets – CVD – Sacubitril valsartan position statement Jan 19 final new (Requires review)Tower Hamlets – CVD – Sacubitril valsartan position statement Jan 19 final new (Requires review)2023/09/20
3629Tower Hamlets – CVD – Sacubitril Valsartan fact sheet (Requires review)Tower Hamlets – CVD – Sacubitril Valsartan fact sheet (Requires review)2023/09/20
3627Tower Hamlets – CVD – Rivaroxaban (Xarelto®) for VTE: Transfer of Care Document (Requires review)Tower Hamlets – CVD – Rivaroxaban (Xarelto®) for VTE: Transfer of Care Document (Requires review)2023/09/20
3625Tower Hamlets – CVD – Rivaroxaban (Xarelto®) for AF: Transfer of Care Document (Requires review)Tower Hamlets – CVD – Rivaroxaban (Xarelto®) for AF: Transfer of Care Document (Requires review)2023/09/20
3623Tower Hamlets – CVD – Rivaroxaban (Xarelto) counselling checklist (Requires review)Tower Hamlets – CVD – Rivaroxaban (Xarelto) counselling checklist (Requires review)2023/09/20
3621Tower Hamlets – CVD – Prescribing Guide for the Initiation of Dapagliflozin for Heart Failure (Requires review)Tower Hamlets – CVD – Prescribing Guide for the Initiation of Dapagliflozin for Heart Failure …2023/09/20
3617Tower Hamlets – CVD – Edoxaban (Lixiana®) for VTE: Transfer of Care Document (Requires review)Tower Hamlets – CVD – Edoxaban (Lixiana®) for VTE: Transfer of Care Document (Requires review)2023/09/20
3614Tower Hamlets – CVD – Edoxaban (Lixiana®) for AF: Transfer of Care Document (Requires review)Tower Hamlets – CVD – Edoxaban (Lixiana®) for AF: Transfer of Care Document (Requires review)2023/09/20
3611Tower Hamlets – CVD – Edoxaban (Lixiana) counselling checklist (Requires review)Tower Hamlets – CVD – Edoxaban (Lixiana) counselling checklist (Requires review)2023/09/20
3609Tower Hamlets – CVD – Dronedarone Position Statement and Prescribing Guide (Requires review)Tower Hamlets – CVD – Dronedarone Position Statement and Prescribing Guide (Requires review)2023/09/20
3602Tower Hamlets – CVD – Dabigatran (Pradaxa®) for VTE: Transfer of Care Document (Requires review)Tower Hamlets – CVD – Dabigatran (Pradaxa®) for VTE: Transfer of Care Document (Requires review)2023/09/20
3599Tower Hamlets – CVD – Dabigatran (Pradaxa®) for AF: Transfer of Care Document (Requires review)Tower Hamlets – CVD – Dabigatran (Pradaxa®) for AF: Transfer of Care Document (Requires review)2023/09/20
3597Tower Hamlets – CVD – Dabigatran (Pradaxa) counselling checklist (Requires review)Tower Hamlets – CVD – Dabigatran (Pradaxa) counselling checklist (Requires review)2023/09/20
3592Tower Hamlets – CVD – Apixaban in AF: Transfer of Care Document (Requires review)Tower Hamlets – CVD – Apixaban in AF: Transfer of Care Document (Requires review)2023/09/19
3590Tower Hamlets – CVD – Apixaban for VTE: Transfer of Care Document (Requires review)Tower Hamlets – CVD – Apixaban for VTE: Transfer of Care Document (Requires review)2023/09/19
3588Tower Hamlets – CVD – Apixaban (Eliquis) counselling checklist (Requires review)Tower Hamlets – CVD – Apixaban (Eliquis) counselling checklist (Requires review)2023/09/19
3580Tower Hamlets – CVD – Amiodarone Position Statement and Prescribing Guide (Requires review)Tower Hamlets – CVD – Amiodarone Position Statement and Prescribing Guide (Requires review)2023/09/19
3575Tower Hamlets – Respiratory – Air Liquide Part A Portal April 2020 Update (Requires review)Tower Hamlets – Respiratory – Air Liquide Part A Portal April 2020 Update (Requires review)2023/09/19
3572Tower Hamlets – Diabetes – Agamatrix Wavesense Jazz Memo (Requires review)Tower Hamlets – Diabetes – Agamatrix Wavesense Jazz Memo (Requires review)2023/09/19
3568Tower Hamlets – Diabetes – Advice for Pharmacists – High Strength Insulins (Requires review)Tower Hamlets – Diabetes – Advice for Pharmacists – High Strength Insulins (Requires review)2023/09/19
3564Tower Hamlets – Diabetes – Advice for Healthcare Professionals – High Strength Insulins (Requires review)Tower Hamlets – Diabetes – Advice for Healthcare Professionals – High Strength Insulins (Requires review)2023/09/19
3560Tower Hamlets – Respiratory – Adult Allergic Rhinitis Guidelines 2019 (Requires review)Tower Hamlets – Respiratory – Adult Allergic Rhinitis Guidelines 2019 (Requires review)2023/09/19
3556Tower Hamlets – Shared Care Guideline – Adult ADHD SCG 2021 (Requires review)Tower Hamlets – Shared Care Guideline – Adult ADHD SCG 2021 (Requires review)2023/09/19
3552Prescribing Quality Efficiency Scheme 2023.24 Launch Letter FinalPrescribing Quality Efficiency Scheme 2023.24 Launch Letter Final2023/09/19
3544CAMHS2023/09/19
3533Paeds PhlebotomyPaeds Phlebotomy Training Slides – Read-Only (3)2023/09/19
3530TH Circumcision ServicesCircumcision Services for Baby Boys in Tower Hamlets booklet FINAL Nov 20152023/09/19
3522Key Imms Resource listKey Imms Resource list2023/09/19
3514CYP in Primary CareCYP in Primary Care, 27.4.20 (2)2023/09/19
3500TH FGM Flow chartTH FGM flow chart2023/09/19
3498Talking about FGMTalking about FGM – GPs Feb 20222023/09/19
3496DH FGM Risk and safeguardingDH FGM Risk and safeguarding(1)2023/09/19
3493FGM Risk assessment for WHETHER THE CHILD HAS HAD FGM(1)FGM Risk assessment for WHETHER THE CHILD HAS HAD FGM(1)2023/09/19
3490FGM Risk assessment for PREGNANT WOMEN Risks to mother and unborn childFGM Risk assessment for PREGNANT WOMEN Risks to mother and unborn child(1)2023/09/19
3488FGM Risk Assessment for NON PREGNANT ADULT WOMENFGM Risk Assessment for NON PREGNANT ADULT WOMEN(1)2023/09/19
3481FGM Risk Assessment for CHILDRENFGM Risk Assessment for CHILDREN(1)2023/09/19
3477Pathway new diabetes for GPsPathway new diabetes for GPs endorsed NEL 2020-02-27 FINAL2023/09/19
3473treatment and prophylaxis of Nutritional Vitamin D deficiencyPaediatric Vitamin D Guidelines – 20172023/09/19
3470TREATMENT OF RHINITISAlgorithm-RhinitisPCGL(1) (1)2023/09/19
3467discharging ear GuidelineManagement of discharging ear July 2021 v1 (2)2023/09/19
3464Hearing problems – Children GuidelineHearing problems children July 2021 v1 (1)2023/09/19
3461Prolonged Jaundice PathwayProlonged Jaundice pathway flow chart April 2020 GP Midwives HV ED (1)2023/09/19
3457Reflux FinalReflux Final(1)2023/09/19
3445ProteinuriaProteinuria Final(1)2023/09/19
3442Lymphadenopathy guidelineLymphadenopathy Final(1)2023/09/19
3439Limping Child PathwayLimping Child Final(1)2023/09/19
3436Haematuria FinalHaematuria Final(1)2023/09/19
3433Tower Hamlets GP-paediatric referral pathwayTower Hamlets GP-paediatric referral pathway (1)2023/09/19
3428Constipation ManagementConstipation Management Final(1)2023/09/19
3424Chronic Cough GuidelineChronic Cough Final2023/09/19
3420Asthma Diagnostic and Treatment PathwayAsthma Diagnostic and Treatment Pathway – quick reference guide(2)2023/09/19
3418TH Acute Asthma Exacerbation PathwayAcute Asthma Exacerbation Pathway(2)2023/09/19
3413BHTHT Paediatric Asthma GuidelinesTH Paediatric Asthma Guidelines Jan 20202023/09/19
3410Bronchiolitis/RSV PathwayTH Bronchiolitis Pathway v22023/09/19
3407FAQs for GPs Assessing Febrile ChildrenNEL modified FAQs for GPs Assessing Febrile Children_ KSJM 27.10.202023/09/19
3403TH Pan-London Suspected Children’s (under 16) Cancer Referral GuideTH USC-childrens-cancer-clinical-guide2023/09/19
3399TH Pan-London Suspected Sarcoma Referral GuideUSC-Sarcoma-clinical-guide2023/09/19
3385Paeds Phlebotomy Training Slides – Read-Only (1)2023/09/18
3382Paediatric Atopic Eczema Management GuidePaeds atopic eczema treatment 2020 (1)2023/09/18
3379Model declaration formCR Model declaration form A _Barts (1)2023/09/18
3376IG Confidentiality Forms1 – IG Confidentiality Forms (1)2023/09/18
3373Honorary Pre-employment Check FormNHS Passport- Honoray Barts Contract Form (2)2023/09/18
3366Completing starter processElectronic New Starter Form_Hon (1)2023/09/15
3332Health spot referral commshealth spot comms April 2020 (1)2023/09/15
3329Prolonged Jaundice pathwayProlonged Jaundice pathway flow chart April 2020 GP Midwives HV ED2023/09/15
3323OCVC Case Study by NHSE featuring Barking Medical GroupOCVC Case Study by NHSE featuring Barking Medical Group2023/09/15
3302Autistic Spectrum Disorder in ChildrenASD Community Paediatrics referral criteria2023/09/14
3299Tube feeding pathwayTube feeding pathway – final May 20152023/09/14
3290GP GuideGP Guide2023/09/14
3158(NEL) Management of Infection Guidance for Primary CareMM_NEL_Antimicrobial_Prescribing_Guidance_V1.7_Aug232023/09/12
3148Dermatology Photo Taking GuideDermatology Photo Taking Guide2023/09/12
3127NHS App For Repeat Prescriptions Toolkit_ Tracking NHS App DataNEWNHS App For Repeat Prescriptions Toolkit_ Tracking NHS App Data2023/09/11
3125NHS App For Repeat Prescriptions Toolkit_ Promoting the app to PatientsNEWNHS App For Repeat Prescriptions Toolkit_ Promoting the app to Patients2023/09/11
3123NHS App For Repeat Prescriptions Toolkit_ Increasing Uptake of the AppNEWNHS App For Repeat Prescriptions Toolkit_ Tracking NHS App Data2023/09/11
3120Nutrition & Blood – (NH & WF) Electronic Prescription Service (EPS) Implementation at Fresenius-KabiPatient Safety Information Home Enteral Feeding2023/09/09
3113Nutrition & Blood – (NH & WF) Home Enteral tube feeds for Adults & Infants Fresenius KabiGP ONE-OFF-NOM LETTER2023/09/09
2995(BHR) Trimipramine guidance- stopping or switching to alternative therapyTrimipramine-switching-or-stopping2023/09/04
2992(BHR) Dosulepin guidance- stopping or switching to alternative therapyDosulepin-switching-or-stopping2023/09/04
2980(BHR) Oxycodone recommended brandsOxycodone_brands2023/08/30
2976(BHR) BHR CCGs’ recommended calcium and vitamin D productsGuidance_changing_Daily_Calcium_Vit D2023/08/30
2974(BHR) BHR CCGs and BHRUT updated osteoporosis pathwayjoint_osteoporosis_pathway2023/08/30
2972(BHR) BHR CCGs and BHRUT transfer of care monitoring and guidance for denosumab in post menopausal women with osteoporosisTransfer_of_care_DENOSUMAB2023/08/30
2967(BHR) Vaccine fridge temperature out of range guidanceCold_Chain_guidance2023/08/30
2961(BHR) Smoking Cessation servicesSmoking_Cessation_Service2023/08/30
2955(BHR) End of Life Care (EoLC) access to medicines service from community pharmacies across Barking and Dagenham, Havering and RedbridgeBHR_EOL_Commissioned_pharmacies2023/08/30
2944(BHR) Patient information leaflet – Maintaining vitamin D levels for adults FAQs(BHR) Patient information leaflet – Maintaining vitamin D levels for adults FAQs2023/08/30
2942(BHR) Vitamin D formulary guidance(BHR) Vitamin D formulary guidance2023/08/30
2940(BHR) Vitamin D paediatric (<18 years) deficiency with eGFR >30ml/min primary care pathway(BHR) Vitamin D paediatric 18 years deficiency with eGFR 30mlmin primary care pathway2023/08/30
2938(BHR) Vitamin D adult deficiency guidance(BHR) Vitamin D adult deficiency guidance2023/08/30
2929(BHR) Drug and Alcohol servicesDrug_Alcohol_Service2023/08/30
2922(BHR) Variable use repeat dispensing guideVariable_Use_Repeat_Dispensing_Guide2023/08/30
2920(BHR) Prescribing Dilemmas: A Guide for PrescribersPrescribing_Dilemmas_guidance2023/08/30
2918(BHR) Monitored dosage system (MDS) 7 day vs 28 day dispensingMDS_dispensing2023/08/30
2916(BHR) Memorandum of understanding between BHR GP practices and private sector organisations for shared care agreementsMOU_Private-NHS_sharedcare2023/08/30
2914(BHR) Interface prescribing policyInterface_Prescribing_Policy2023/08/30
2912(BHR) Amending prescriber codesAmending_prescriber_codes2023/08/30
2910(BHR) Adding safety messages to patient prescriptionsadding_safety_messages2023/08/30
2908(BHR) Acute and Repeat prescribing(BHR) Acute and Repeat prescribing2023/08/30
2859HOOF_AB_FormsHOOF_AB_Forms2023/08/29
2843Checklist for initiating SGLT2i (canagliflozin, empagliflozin, dapagliflozin and ertugliflozin)Checklist for initiating SGLT2i (canagliflozin, empagliflozin, dapagliflozin and ertugliflozin)2023/08/25
2829Tower Hamlets Adult ADHD presentation for 11 11 2021 vfinalTower Hamlets Adult ADHD presentation for 11 11 2021 vfinal2023/08/25
2817CTS Process MapCTS Process Map2023/08/25
2815Crisis Response Team process mapCrisis Response Team process map2023/08/25
2813Crisis Response Team Pathway for GPsCrisis Response Team Pathway for GPs2023/08/25
2811Crisis pathway mapping slideCrisis pathway mapping slide2023/08/25
2801Crisis line and Cafe flyer with cafe numberCrisis line and Cafe flyer with cafe number2023/08/25
2777NHS App For Repeat Prescriptions Toolkit_ Promoting the app to PatientsNewNHS App For Repeat Prescriptions Toolkit_ Promoting the app to PatientsNew2023/08/25
2759Tower Hamlets Eating Disorder RAG ratingTower Hamlets Eating Disorder RAG rating2023/08/24
2730NEL_Antimicrobial_Prescribing_Guidance_V1.7_Apr23 (restricted version) (1)NEL_Antimicrobial_Prescribing_Guidance_V1.7_Apr23 (restricted version) (1)2023/08/24
2682(BHR) UKMI switching between liquid and tablet/capsules- which medicines require extra care?UKMI_QA_Which-medicines-require-extra-care-when-switching-between-liquid-and-tablet-Update_July_2021_Final2023/08/21
2673(BHR) Emergency oxygen use in GP practices adult guidelineEmergency_Oxygen_Practices2023/08/20
2671(BHR) IHORM guidanceIHORM_guidance2023/08/20
2669(BHR) FAQs on the updated HOOF form, IHORM form and consentFAQ_IHORM_Consent2023/08/20
2667(BHR) Contact information for the Community BHR Home Oxygen Services Assessment & Review (HOS-AR)BHR_HOS_AR_Services2023/08/20
2665(BHR) SitagliptinSitagliptin2023/08/20
2663(BHR) SimvastatinSimvastatin2023/08/20
2661(BHR) SertralineSertraline2023/08/20
2659(BHR) Saxagliptinsaxagliptin2023/08/20
2657(BHR) Rosuvastatinrosuvastatin2023/08/20
2655(BHR) RiboflavinRiboflavin2023/08/20
2653(BHR) RamiprilRamipril2023/08/20
2651(BHR) QuetiapineQuetiapine2023/08/20
2649(BHR) PrednisolonePrednisolone2023/08/20
2647(BHR) OxybutyninOxybutynin2023/08/20
2644(BHR) OmeprazoleOmeprazole2023/08/20
2642(BHR) NitrofurantoinNitrofurantoin2023/08/20
2640(BHR) MirtazapineMirtazapine2023/08/20
2638(BHR) MetoclopramideMetoclopramide2023/08/20
2636(BHR) MemantineMemantine2023/08/20
2634(BHR) MagnesiumMagnesium2023/08/20
2632(BHR) MacrogolMacrogol2023/08/20
2630(BHR) LosartanLosartan2023/08/20
2628(BHR) LinagliptinLinagliptin2023/08/20
2626(BHR) LevothyroxineLevothyroxine2023/08/20
2624(BHR) LansoprazoleLansoprazole2023/08/20
2622(BHR) HydrocortisoneHydrocortisone2023/08/20
2620(BHR) GlycopyrroniumGlycopyrronium2023/08/20
2618(BHR) GabapentinGabapentin2023/08/20
2616(BHR) FurosemideFurosemide2023/08/20
2614(BHR) Folic acidFolic_Acid2023/08/20
2612(BHR) Esomeprazole tabletEsomeprazole_tablet2023/08/20
2610(BHR) Esomeprazole sachetEsomeprazole_sachet2023/08/20
2608(BHR) Diltiazem topicalDiltiazem_topical2023/08/20
2606(BHR) DexamethasoneDexamethasone2023/08/20
2604(BHR) DapagliflozinDapagliflozin2023/08/20
2602(BHR) CyanocobalaminCyanocobalamin2023/08/20
2600(BHR) ClonidineClonidine2023/08/20
2598(BHR) ClonazepamClonazepam2023/08/20
2596(BHR) CitalopramCitalopram2023/08/20
2594(BHR) CaptoprilCaptopril2023/08/20
2592(BHR) BiotinBiotin2023/08/20
2590(BHR) AnastrozoleAnastrozole2023/08/20
2588(BHR) AmlodipineAmlodipine2023/08/20
2586(BHR) Alendronic acid (Alendronate)Alendronic_acid_Alendronate2023/08/20
2584(BHR) AcetylcysteineAcetylcysteine2023/08/20
2582(BHR) Can thickeners be added to medication? thickening_medications2023/08/20
2580(BHR) Specials guide introductionSpecials_intro2023/08/20
2574(BHR) Barking and Dagenham, Havering and Redbridge specials guidance on the use of unlicensed medicines – last updated May 2017Specials2023/08/20
2572(BHR) Gluten-free diet patient information leafletGFdietadvice2023/08/20
2570(BHR) Cow’s Milk Protein Allergy (CMPA) infant formula paediatric prescribing guidelineCMPA_guideline (1)2023/08/20
2568(BHR) Thickening ONS guidance  Thickening_ONS_guidance2023/08/20
2566(BHR) Thickener guidanceThickener_Guidance2023/08/20
2564(BHR) Guidance for prescribing of drugs in erectile dysfunction in primary careErectile_dysfunction_guidance2023/08/20
2562(BHR) Recommended CCG oral contraceptive brands – joint letter June 2014contraceptive_letter_20142023/08/20
2549(BHR) BHRUT Pharmacy bulletin- Loperamide formulations for high output stoma/ short bowel syndromeBHRUT_stoma_bulletin2023/08/20
2539(BHR) Insulin therapy BHRUTType2_insulin2023/08/20
2537(BHR) Pen needle prescribing and safe sharps disposalpen_needle_sharps2023/08/20
2533(BHR) DMC dermatology formulary (community service provider)DMC_Formulary2023/08/20
2531(BHR) Patient information leaflet- emollientsPIL_Emollient2023/08/20
2529(BHR) Emollient guidelines and formularyEmollient_Formulary2023/08/20
2505Cow’s Milk Protein Allergy (CMPA) infant formula paediatric prescribing guidelineCMPA_guideline2023/08/20
2503School Guide FAQs on spare/back up adrenaline autoinjectorsAAI_School_Guide_FAQ2023/08/20
2501Practice template letter for the provision of adrenaline autoinjectors for schoolsLetter_AAI_provision_schools (1)2023/08/20
2497Adrenaline autoinjectors – Guidance on provision for anaphylaxis in primary careGuidelines_AAI_provision2023/08/20
2439Position statement on the prescribing for WartsPS_warts2023/08/19
2437Position statement on the prescribing of Vitamin DPS_vitaminD2023/08/19
2435Position statement on the prescribing of Travel vaccinesPS_travel_vaccines2023/08/19
2433Position statement on the prescribing of Travel sickness OTC treatmentPS_travelsickness2023/08/19
2431Position statement on the prescribing of Threadworm treatmentPS_threadworm2023/08/19
2429Position statement on the prescribing of Tadalafil once dailyPS_Tadalafil_oncedaily2023/08/19
2427Position statement on the prescribing of SuncreamsPS_suncream2023/08/19
2425Position statement on the prescribing for SunburnPS_Sunburn2023/08/19
2423Position statement on the prescribing of Sleeping OTC treatmentPS_sleeping2023/08/19
2419Position statement on the prescribing for Skin rashes treatmentPS_skinrashes2023/08/19
2417Position statement on the prescribing of Silk garmentsPS_Silk2023/08/19
2414Position statement on the prescribing of RubefacientsPS_rubefacients2023/08/19
2412Position statement on the prescribing of ProbioticsPS_probiotics2023/08/19
2410Position statement on the prescribing of PerindoprilPS_Perindopril_arginine2023/08/19
2408Position statement on the prescribing of Pen needlesPS_pen_needles2023/08/19
2406Position statement on the prescribing of Paracetamol and TramadolPS_Paracetamol_Tramadol2023/08/19
2404Position statement on the prescribing of Paracetamol and IbuprofenPS_paracetamol_and_ibuprofen2023/08/19
2402Position statement on the prescribing of Oxycodone and NaloxonePS_Oxycodone_Naloxone2023/08/19
2400Position statement on the prescribing for Oral ThrushPS_oralthrush2023/08/19
2398Position statement on the prescribing of Omega-3 and fish oilsPS_omega3_fishoils2023/08/19
2396Position statement on the prescribing of Multivitamins and mineralsPS_multivitamins_minerals2023/08/19
2394Position statement on the prescribing of MinocyclinePS_minocycline2023/08/19
2392Position statement on the prescribing of Milk formula (non-specialist)PS_milk_form2023/08/19
2390Position statement on the prescribing for MigrainesPS_Migraines2023/08/19
2388Position statement on the prescribing of Liothyronine (and Armour Thyroid)PS_Liothyronine2023/08/19
2386Position statement on the prescribing of Lidocaine plastersPS_Lidocaine_plasters2023/08/19
2384Position statement on the prescribing for IndigestionPS_indigestion2023/08/19
2382Position statement on the prescribing for HyperhidrosisPS_Hyperhydrosis2023/08/19
2380Position statement on the prescribing of HomeopathyPS_Homeopathy2023/08/19
2378Position statement on the prescribing of Homely remedies in care homesPS_Homely_Remedies2023/08/19
2376Position statement on the prescribing of Herbal treatmentPS_Herbal2023/08/19
2374Position statement on the prescribing of Head lice and scabies treatmentPS_headlice_scabies2023/08/19
2372Position statement on the prescribing for Hayfever OTC treatmentPS_hayfever2023/08/19
2370Position statement on the prescribing for HaemorrhoidsPS_Haemorrhoids2023/08/19
2368Position statement on the prescribing of Gluten free foodsPS_glutenfree2023/08/19
2366Position statement on the prescribing of Glucosamine and ChondroitinPS_Glucosamine_Chondroitin2023/08/19
2364Position statement on the prescribing of Flash Glucose monitoringPS_Flash_Glucose_Monitoring2023/08/19
2362Position statement on the prescribing of Fentanyl immediate releasePS_FentanylIR2023/08/19
2360Position statement on the prescribing of Eye vitaminsPS_eye_vitamins2023/08/19
2358Position statement on the prescribing of EflornithinePS_Eflornithine2023/08/19
2356Position statement on the prescribing for Ear waxPS_earwax2023/08/19
2354Position statement on the prescribing for Dry skinPS_dryskin2023/08/19
2352Position statement on the prescribing for Dry or sore eyesPS_dry_sore_eye2023/08/19
2350Position statement on the prescribing of DronedaronePS_Dronedarone2023/08/19
2348Position statement on the prescribing of Doxazosin m/rPS_Doxazosinmr2023/08/19
2346Position statement on the prescribing for DiarrhoeaPS_Diarrhoea2023/08/19
2344Position statement on the prescribing for Dental and oral conditionsPS_dental_oral_medicines2023/08/19
2342Position statement on the prescribing for DandruffPS_Dandruff2023/08/19
2340Position statement on the prescribing for CystitisPS_Cystitis2023/08/19
2338Position statement on the prescribing for Cradle capPS_Cradlecap2023/08/19
2336Position statement on the prescribing of Cough and cold remediesPS_cough_cold_remedies2023/08/19
2334Position statement on the prescribing for ConstipationPS_Constipation2023/08/19

This website is for healthcare professions only.

It is not for public use.

Feedback
Feedback
How would you rate your experience?
Do you have any additional comment?
Next
Enter your email if you'd like us to contact you regarding with your feedback.
Back
Submit
Thank you for submitting your feedback!